Wolters Kluwer Health announces today that it has completed the divestment of ProVation Medical to Clearlake Capital Group, L.P.
As originally announced on January 11, 2018.
CorporateInvestorsHealthMarch 09, 2018
Wolters Kluwer Health completes divestment of ProVation
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software solutions and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
-
Press ReleaseHealthDecember 17, 2024Wolters Kluwer “25 for ‘25” report predicts key healthcare technology trends driving momentum amid dramatic change in 2025The prediction report features 25 wide-ranging predictions spanning health AI, preventing burnout, tech for the next generation, smarter clinical surveillance, M&A, and more. -
Press ReleaseCorporateInvestorsDecember 09, 2024Wolters Kluwer appoints Mark Sherwood as Executive Vice President & Chief Information OfficerWolters Kluwer, a global leader in professional information, software solutions, and services, has appointed Mark Sherwood as Executive Vice President & Chief Information Officer (CIO).
-
Global NewsCorporateESGNovember 21, 2024Wolters Kluwer executive wins two leadership awardsKaren Abramson, CEO of Corporate Performance & ESG has been named as a Silver Winner in both the 2024 Stevie® Awards for Women in Business and the 2024 Globee® Awards for Women in Business.